In contrast to the lack of an anti-obesity effect in Leprdb mice, FEN decreased fasting hyperglycaemia and glucose intolerance and increased pancreatic islet mass and circulating insulin. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.